← Back to Clinical Trials
Recruiting NCT05225402

Hemodynamic Measurements of Macrocirculatory and Perfusion Parameters in ICU

Trial Parameters

Condition Septic Shock
Sponsor Copenhagen University Hospital, Hvidovre
Study Type OBSERVATIONAL
Phase N/A
Enrollment 45
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2022-03-08
Completion 2025-07-30
Interventions
Hemodynamic measurements during reduction in Norepinephrine and fluid boli.

Brief Summary

In septic shock there is growing evidence of a state of hemodynamic "disconnection" with seemingly adequate macrocirculatory values despite actual microcirculation failing to meet cellular demand. Norepinephrine (NE) is recommended as first choice vasoactive agent for the treatment of septic shock. However, the dynamic effects of NE on macro- and microcirculation and perfusion parameters has not been described in detail in the context of septic shock, precluding rational individualized titration of NE and fluids, as recommended recently. In the present prospective observational multicenter study in adult septic shock patients, we intend to explore the effects of NE on preload dependency and tissue perfusion by evaluating the correlation and potential discrepancies between macro- and microcirculation both during titration of NE and after fluid resuscitation. The conclusions drawn from our study will contribute to the physiological knowledge necessary for establishing individualized evidence-based bedside management of hemodynamics in the setting of septic shock.

Eligibility Criteria

Inclusion Criteria: * Suspected or documented infection * Need for vasopressors to maintain mean arterial blood pressure (MAP) ≥65 mmHg * Serum lactate levels \>2 mmol/L * Norepinephrine infusion of \> 0.2 mcg/kg/min Exclusion Criteria: * Absolute contraindication for esophageal doppler or urinary catheter insertion as noted in the patients' charts. * Severe valvular pathology and cardiac arrhythmias resulting in severe hemodynamic instability. * Lithium treatment * Treatment with other vasopressor or inotropic drugs.

Related Trials